Literature DB >> 10591049

Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR analysis.

A E Medvedev1, R R Ramsay, A S Ivanov, A V Veselovsky, V I Shvedov, O V Tikhonova, A P Barradas, C K Davidson, T A Moskvitina, O A Fedotova, L N Axenova.   

Abstract

A series of pirlindole analogues were tested as inhibitors of monoamine oxidase A and B. Although we did not find strict dependence between 3D-size of molecules and their inhibitory potency, rigid analogues exhibited potent and selective inhibition of MAO-A. They have 3D size limits of 13 angstroms (length) x 7 angstroms (height) x 4.4 angstroms (widths). Besides MAO-A inhibition flexible analogues also demonstrated potent inhibition of MAO-B. Five compounds were studied as inhibitors of purified human liver MAO-A. Their inhibitory potencies coincided with those obtained using rat liver mitochondrial MAO-A. Each compound induced changes in the spectrum of MAO-A but these did not correlate with the flexibility of the derivative. It is also possible that the oxygen bridge introduced with the flexibility might influence spectral patterns.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10591049

Source DB:  PubMed          Journal:  Neurobiology (Bp)        ISSN: 1216-8068


  4 in total

1.  Optimization of a mathematical topological pattern for the prediction of antihistaminic activity.

Authors:  M J Duart; R García-Domenech; G M Antón-Fos; J Gálvez
Journal:  J Comput Aided Mol Des       Date:  2001-06       Impact factor: 3.686

Review 2.  Kinetics, mechanism, and inhibition of monoamine oxidase.

Authors:  Rona R Ramsay; Alen Albreht
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

3.  Monoamine oxidase inhibitory activities of novel 3,4-dihydroquinolin-(1H)-2-one derivatives.

Authors:  S G Sunal; S Yabanoglu; A Yesilada; G Ucar
Journal:  J Neural Transm (Vienna)       Date:  2007-03-26       Impact factor: 3.575

4.  Computer visualisation of the active site of monoamine oxidase-A by means of selective inhibitors.

Authors:  Alexei E Medvedev; Alexis S Ivanov; Alexander V Veselovsky
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.